Company intelligence / Profile preview

Supercoiled GeneTx

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Supercoiled GeneTx is a preclinical-stage biotechnology company focused on developing a new class of DNA-based medicines. The company leverages its proprietary supercoiled DNA (scDNA) platform to create highly stable and efficient non-viral gene therapies. By optimizing the topological structure of DNA, Supercoiled GeneTx aims to overcome the limitations of traditional viral vectors, such as immunogenicity and limited cargo capacity. Their primary therapeutic focus includes addressing complex neurological disorders and rare genetic diseases through precise and durable gene expression.

Therapeutic areas: NeurologyRare Diseases
Modalities: Gene therapyDNA-based therapyNon-viral delivery
Industry: Biotech

Beyond the preview

Go deeper on Supercoiled GeneTx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supercoiled GeneTx.

Explore the full profile